Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Muller

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
The Biochemical Journal|May 1, 1995
Expression of haemopexin receptors by cultured human cytotrophoblastH P van Dijk, M J Kroos, J S Starreveld, et al.
Hepatology (Baltimore, Md.)|September 1, 1994
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytesP R Sinclair, W J Bement, J F Healey, et al.
The Journal of Physiology|March 19, 2005
Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiationFranco A Taverna, John Georgiou, Robert J McDonald, et al.
The American Journal of Physiology|June 25, 1998
Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatasesI Gombosova, P Boknik, U Kirchhefer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2010
Attention-like modulation of hippocampus place cell dischargeAndré A Fenton, William W Lytton, Jeremy M Barry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 3, 2007
Inhibition of kainate receptors reduces the frequency of hippocampal theta oscillationsJohn R Huxter, Larissa E Zinyuk, Eva v L Roloff, et al.
Arthritis and Rheumatism|November 11, 1999
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritisM M Maurice, H Nakamura, S Gringhuis, et al.
Oncogene|December 6, 2011
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancerE S Ratner, F K Keane, R Lindner, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
The Biochemical Journal|May 1, 1995
Expression of haemopexin receptors by cultured human cytotrophoblastH P van Dijk, M J Kroos, J S Starreveld, et al.
Hepatology (Baltimore, Md.)|September 1, 1994
Effects of hemopexin on heme-mediated repression of 5-aminolevulinate synthase and induction of heme oxygenase in cultured hepatocytesP R Sinclair, W J Bement, J F Healey, et al.
The Journal of Physiology|March 19, 2005
Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiationFranco A Taverna, John Georgiou, Robert J McDonald, et al.
The American Journal of Physiology|June 25, 1998
Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatasesI Gombosova, P Boknik, U Kirchhefer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2010
Attention-like modulation of hippocampus place cell dischargeAndré A Fenton, William W Lytton, Jeremy M Barry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 3, 2007
Inhibition of kainate receptors reduces the frequency of hippocampal theta oscillationsJohn R Huxter, Larissa E Zinyuk, Eva v L Roloff, et al.
Arthritis and Rheumatism|November 11, 1999
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritisM M Maurice, H Nakamura, S Gringhuis, et al.
Oncogene|December 6, 2011
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancerE S Ratner, F K Keane, R Lindner, et al.
Pageof 20